Please login to the form below
Webinars
-
Wednesday, 7 November 2018 - 3:00 pm
Beyond the Blame Game: Improving Patient, Physician, Pharma RelationsWe often hear patients report a lack of ‘connection’ with their physician, and where lifestyle plays a role in the development of a disease, such as obesity or type 2 diabetes, patients may even feel the doctor blames them for their condition.
Andrew McConaghie, Group Editor
FREE | VIEW NOW
-
Thursday, 14 December 2017 - 2:00 pm
Transforming Access to Medicines Through Patient-Centric SolutionsAs medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 30 November 2017 - 2:00 pm
The Future of Marketing in Life Sciences: Is your function fit for purposeThe healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 15 November 2017 - 3:00 pm
The Power of Storytelling in Health: Friend or Foe?With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 19 October 2017 - 3:00 pm
The Truth about Doctors‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and how we can improve the way we communicate to them.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 10 October 2017 - 3:00 pm
Proving the Strategic Value of PatientsPatient insights aren’t just a ‘nice to have’: they are essential to understand the space where Pharma’s drugs ‘live’.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 11 July 2017 - 3:00 pm
Regret MinimisationWhen new products approach the market the level of demand for them is often exaggerated.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 19 April 2017 - 3:00 pm
Assessing early market opportunityTo successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 24 January 2017 - 3:00 pm
PC: Are you Patient Centric or just Politically Correct?Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Monday, 28 November 2016 - 3:00 pm
Communicating innovation to payers and policy makersInvolving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 17 November 2016 - 3:00 pm
Immuno-oncology's evolution: implications for pharma market researcheImmuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 9 November 2016 - 2:00 pm
Scale & Strategy: Essential tools for transforming the commercial modelMost life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 25 October 2016 - 3:00 pm
Driving adoption of Commercial Analytic solutionsMeasuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 4 October 2016 - 3:00 pm
Modelling ‘smart’ and ‘lazy’ thinking to influence decision-makingTraditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 14 September 2016 - 3:00 pm
Strengthening market access deliverables by harnessing the patient journeyIn today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 13 July 2016 - 3:00 pm
The value of early asset development and commercialisationLinking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets to succeed.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 30 June 2016 - 2:00 pm
Developing medical education that advances patient outcomesAs pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice and advancing patient outcomes.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 19 May 2016 - 3:00 pm
Customer engagement design in pharmaIn recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 22 March 2016 - 3:00 pm
Rare diseases: Regulatory and reimbursement submissions, the challengesCompanies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 10 February 2016 - 3:00 pm
Meaningful digital initiatives need face timeDoctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.
Dominic Tyer, Editorial director
FREE | VIEW NOW
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Digital strategist
-
Competitive
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- GSK reveals plans for £400m R&D facility expansion in England
- EU approves bluebird bio’s CALD gene therapy Skysona
- NHS earmarks £340m for new medicines fund to fast-track ‘innovative’ treatments
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- Onyx Health Launch Creative Studio After Record Year
- Kriya Therapeutics raises $100m to further develop gene therapies with ‘broader applications’
- Lilly and Banner Alzheimer’s Institute collaborate on donanemab prevention trial
- Positive prospects for pharma in Latin America
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Biosimilars in China
PMHub
TRIDUCIVE
Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
